Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1350 of 3284 entries
View as:

A Ph1 Study in Healthy Male Japanese and Caucasian After Single and Multiple Doses of D5884(Omega-3-carboxylic Acids)

Phase: N/A Priority: Normal
NCT ID: NCT02209766 Org: User:
Start: 08/31/14 End: 11/30/14 Due: 11/30/15

ZD 1839 Plus Combination Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00006048 Org: User:
Start: 05/31/00 End: - Due: -

Phase 1 Bioequivalence Study of Dapagliflozin/Sitagliptin FDC vs Loose Combination of Single Components

Phase: N/A Priority: Normal
NCT ID: NCT05266404 Org: User:
Start: 03/21/22 End: 05/31/22 Due: 05/31/23

To Evaluate the Response to Glucagon During Hypoglycemia

Phase: N/A Priority: Normal
NCT ID: NCT00817271 Org: User:
Start: 02/28/09 End: 04/30/09 Due: 04/30/10

Machine-Learning Algorithm for Prediction of Blood Pressure, Glycated Haemoglobin and Estimated Glomerular Filtration Rate

Phase: N/A Priority: Normal
NCT ID: NCT04814680 Org: User:
Start: 11/08/21 End: 02/10/22 Due: 02/10/23

Electronic Health Record (EHR)-Based Intervention for Gastroesophageal Reflux Disease (GERD) and Chronic Non-steroidal Anti-inflammatory Drug (NSAID) Use

Phase: N/A Priority: Normal
NCT ID: NCT00691171 Org: User:
Start: 01/31/07 End: 06/30/08 Due: 06/30/09

A Multi-Centre, Prospective, Non-Interventional Study to Intensively Monitor the Safety of Osimertinib in Clinical Practice Among Chinese NSCLC Patients

Phase: N/A Priority: Normal
NCT ID: NCT03485326 Org: User:
Start: 04/21/20 End: 08/03/23 Due: 08/03/24

Efficacy and Safety of Benralizumab in EGPA Compared to Mepolizumab.

Phase: N/A Priority: Normal
NCT ID: NCT04157348 Org: User:
Start: 10/29/19 End: 03/31/26 Due: 03/31/27

Study of the Effect of Dapagliflozin on the Pharmacokinetics of Warfarin or Digoxin in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00904176 Org: User:
Start: 06/30/09 End: 08/31/09 Due: 08/31/10

Titratable Dosing in Moderate to Severe Asthmatics

Phase: N/A Priority: Normal
NCT ID: NCT00651768 Org: User:
Start: 08/31/03 End: 01/31/05 Due: 01/31/06

The Clinical Significance of Minimal Change in Reflux Esophagitis Based on the Gastroesophageal Reflux Disease Questionnaire

Phase: N/A Priority: Normal
NCT ID: NCT00901004 Org: User:
Start: 04/30/09 End: 09/30/09 Due: 09/30/10

Observation of Change in Clinical Global Impression Scores in Schizophrenia Patients Receiving Seroquel XR Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00758251 Org: User:
Start: 09/30/08 End: 03/31/09 Due: 03/31/10

Progression of Carotid Artery Atheroma in Moderately Hypercholesterolemic Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00654394 Org: User:
Start: 01/31/00 End: 08/31/04 Due: 08/31/05

Liver Safety Under Upfront Arimidex vs Tamoxifen

Phase: N/A Priority: Normal
NCT ID: NCT00537771 Org: User:
Start: 09/30/07 End: 12/31/11 Due: 12/31/12

GALLEX 1 - Long Term Extension Study in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00252876 Org: User:
Start: 03/31/05 End: 01/31/07 Due: 01/31/08

Validation of RDQ Questionnaire

Phase: N/A Priority: Normal
NCT ID: NCT00291746 Org: User:
Start: 09/30/05 End: 11/30/06 Due: 11/30/07

Post-Marketing Surveillance Study: 12 To 24 Weeks Study On The Treatment Emergent Adverse Events In Patients With Type 2 Diabetes Taking Exenatide In Korea

Phase: N/A Priority: Normal
NCT ID: NCT02090673 Org: User:
Start: 02/28/09 End: 03/31/14 Due: 03/31/15

A Study to Investigate the Impact of Dose and Dosing Frequency of AZD8848 on the Response on Biomarkers

Phase: N/A Priority: Normal
NCT ID: NCT01203124 Org: User:
Start: 11/30/10 End: 02/29/12 Due: 02/28/13

Evaluation of the Drug-drug Interaction Between FosD and Verapamil When Taken Together in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01197781 Org: User:
Start: 09/30/10 End: 10/31/10 Due: 10/31/11

GALLANT 7 Tesaglitazar Add-on to Sulphonylurea

Phase: N/A Priority: Normal
NCT ID: NCT00251940 Org: User:
Start: 07/31/04 End: 03/31/06 Due: 03/31/07

A Retrospective, Non-interventional, Multicenter, Observational Chart Review Study to Explore the Clinical Benefits of Retreatment With TKI in the Real World.

Phase: N/A Priority: Normal
NCT ID: NCT01955681 Org: User:
Start: 12/31/13 End: 08/31/14 Due: 08/31/15

Sopran - Omeprazole Treatment Versus Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00256737 Org: User:
Start: 01/31/98 End: 10/31/05 Due: 10/31/06

Phase I Open Label Dose Escalation Study to Investigate the Safety & Pharmacokinetics of AZD5312 in Patients With Androgen Receptor Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02144051 Org: User:
Start: 05/31/14 End: 03/31/16 Due: 03/31/17

Assessing the Pharmacokinetics of NKTR-118 in Subjects With Renal Impairment Compared to That in Subjects With Normal Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT01372826 Org: User:
Start: 06/30/11 End: 11/30/11 Due: 11/30/12

NIS to Observe Improvement in Global Assessment of Functioning in Patients With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00833456 Org: User:
Start: 02/28/09 End: 11/30/10 Due: 11/30/11